
|Articles|April 5, 2022
WCG Unveils Strategic Alliance Program for CROs
Advertisement
WCG has launched a program to augment the existing capabilities of CROs and further support the work they do in driving innovation in clinical trials. By providing CROs with access to its clinical trial operations data, the WCG CRO Strategic Alliance Program enables CROs to better serve patients and research sponsors, and accelerate the pace at which new therapies are brought to market.
Read more about this new alliance program
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
2
Beyond Revenue Recognition: Rethinking CRO Contracting Through the CURED Shared Performance Contract
3
Applied Clinical Trials at the 2026 DIA Global Annual Meeting: Conversations on Data, Outsourcing, and the Patient Voice
4
ACT Brief: Bridging Site-Sponsor Data Gaps, Major Study Retraction, and TNBC First-Line Approval
5




